About Express Scripts Holding Company
Express Scripts, Inc. is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workersâ€™ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM). PBM segmentâ€™s services include retail network pharmacy management and retail drug card programs, home delivery services, specialty benefit services, patient care contact centers, benefit plan design and consultation, drug formulary management, compliance and therapy management programs, information reporting and analysis programs, rebate programs, and electronic claims processing and drug utilization review. EM segmentâ€™s services include distribution of pharmaceuticals and medical supplies to providers and clinics and healthcare account administration and implementation of consumer-directed healthcare solutions.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Health Care Plans
- Sub-Industry: Health Care Services
- Exchange: NASDAQ
- Symbol: ESRX
- CUSIP: 30219G10
- Previous Close: $71.75
- 50 Day Moving Average: $69.99
- 200 Day Moving Average: $71.59
- 52-Week Range: $64.46 - $80.02
- Trailing P/E Ratio: 13.31
- Foreward P/E Ratio: 9.42
- P/E Growth: 0.80
- Market Cap: $43.46B
- Outstanding Shares: 605,719,000
- Beta: 0.92
- Net Margins: 2.70%
- Return on Equity: 24.99%
- Return on Assets: 7.67%
Companies Related to Express Scripts Holding Company:
- Debt-to-Equity Ratio: 0.96%
- Current Ratio: 0.70%
- Quick Ratio: 0.59%
What is Express Scripts Holding Company's stock symbol?
Express Scripts Holding Company trades on the NASDAQ under the ticker symbol "ESRX."
Where is Express Scripts Holding Company's stock going? Where will Express Scripts Holding Company's stock price be in 2017?
16 brokerages have issued 12-month target prices for Express Scripts Holding Company's stock. Their predictions range from $59.00 to $88.00. On average, they anticipate Express Scripts Holding Company's stock price to reach $77.08 in the next year.
When will Express Scripts Holding Company announce their earnings?
Express Scripts Holding Company is scheduled to release their next quarterly earnings announcement on Monday, April, 24th 2017.
What are analysts saying about Express Scripts Holding Company stock?
Here are some recent quotes from research analysts about Express Scripts Holding Company stock:
- Jefferies Group LLC analysts commented, "We believe ESRX remains a Buy given our view that company fundamentals, including its FCF, are stable and that the stock's valuation is attractive at 9x FY18 P/E. That said, we recognize that headlines surrounding drug pricing pressure and the overhang from ESRX's Anthem contract will drive continued stock volatility NT." (2/17/2017)
According to Zacks Investment Research, "Express Scripts’ fourth-quarter 2016 results were mixed, wherein adjusted earnings topped the Zacks Consensus Estimate, revenues beat the same. In the past three months, the company has underperformed the broader industry with respect to price performance. While the company’s guidance for 2017 was encouraging, tough competition in the Pharmacy Benefit Management space and the persistent drug pricing issue are expected to affect the share price. Express Scripts stands to benefit from increased generic utilization, shift toward mail orders, strong specialty growth and an aging population. The company is focused on the development of both specialty drugs and generics, which are expected to account for 50% of the total drug expenditure by 2018. Further, its SafeGuardRx suite of products is designed to better manage specialty spend in turn, establishing a higher standard for patient outcomes." (2/16/2017)
Credit Suisse Group analysts commented, "We continue to believe ESRX will seek to buy Rite Aid’s PBM unit from Walgreens if the deal closes successfully and possibly add its generic purchasing clout to Walgreen’s buying consortium for added economics. Derivatives: At a time when hapless politicians are wringing their wrists about out of control drug costs, we cite another example of a large government payor tapping PBM solutions for greater savings. As opposed to Anthem, TRICARE utilizes a number of ESRX’s cost management tools in addition to a preferred pharmacy network to better manage its trend. We see the PBM model as more rather than less relevant to the current situation, and we see longer-term enhanced roles for PBMs in Medicare part D and B. Separately, we see AmerisourceBergen as benefiting from the news as Walgreen’s supplier, while Cardinal Health stand to lose some share as CVS’s partner." (10/3/2016)
Who owns Express Scripts Holding Company stock?
Express Scripts Holding Company's stock is owned by a variety of of retail and institutional investors. Top institutional investors include State Street Corp (4.34%), Barrow Hanley Mewhinney & Strauss LLC (2.74%), Dimensional Fund Advisors LP (1.01%), Cedar Rock Capital Ltd. (0.83%), Chieftain Capital Management Inc. (0.79%) and Davis Selected Advisers (0.70%). Company insiders that own Express Scripts Holding Company stock include Christopher A Mcginnis, Everett Neville, Gary Wimberly, Glen D Stettin, Mahon Thomas P Mac, Phyllis S Anderson and Woodrow A Myers Jr.
Who sold Express Scripts Holding Company stock? Who is selling Express Scripts Holding Company stock?
Express Scripts Holding Company's stock was sold by a variety of institutional investors in the last quarter, including FIL Ltd, FMR LLC, Thornburg Investment Management Inc., Barrow Hanley Mewhinney & Strauss LLC, Putnam Investments LLC, Davis Selected Advisers, Brown Advisory Inc. and AQR Capital Management LLC. Company insiders that have sold Express Scripts Holding Company stock in the last year include Christopher A Mcginnis, Everett Neville, Mahon Thomas P Mac, Phyllis S Anderson and Woodrow A Myers Jr.
Who bought Express Scripts Holding Company stock? Who is buying Express Scripts Holding Company stock?
Express Scripts Holding Company's stock was acquired by a variety of institutional investors in the last quarter, including Brave Warrior Advisors LLC, Russell Investments Group Ltd., Elkfork Partners LLC, Asset Management One Co. Ltd., Tyers Asset Management LLC, Chieftain Capital Management Inc., Equity Investment Corp Acquisition Inc and DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main.
How do I buy Express Scripts Holding Company stock?
Shares of Express Scripts Holding Company can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Express Scripts Holding Company stock cost?
One share of Express Scripts Holding Company stock can currently be purchased for approximately $71.75.